Kiora Pharmaceuticals, Inc

KPRXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

4.43M

on 2026-06-30, from 2.92M on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-9 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$100.0M

S-3 of 2025-09-15. None sold under it to 2026-10-05. S-3 ↗

2 of its filings are not read yet.

Warrants

1.28M

Warrants of every class as tagged in the XBRL facts on 2023-08-07. 10-K ↗

Cash

7.9 quarters

$16.8M on 2026-06-30 ÷ $2.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-04-03	Private placement incl. 1.53M pre-funded	3,055,422	not read	$5.0M	8-K ↗